Targeting the VEGF Receptor in Colon Cancer: Lessons Learned from Negative Trials
11:09 Share

In this podcast, Dr. Neal J. Meropol provides his perspective on two large randomized studies of vatalanib in patients with metastatic colorectal cancer.